Jacobson Pharma Corporation Limited (HKG:2633)
Hong Kong
· Delayed Price · Currency is HKD 1.180
+0.020 (1.72%)
Mar 21, 2025, 4:08 PM HKT
HKG:2633 Income Statement
Financials in millions HKD. Fiscal year is April - March.
Millions HKD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Revenue | 1,563 | 1,468 | 1,268 | 1,596 | 1,446 | 1,571 | Upgrade
|
| Revenue Growth (YoY) | 11.58% | 15.79% | -20.55% | 10.35% | -7.99% | 6.31% | Upgrade
|
| Cost of Revenue | 892.02 | 847.32 | 728.68 | 975.02 | 884.83 | 881.48 | Upgrade
|
| Gross Profit | 670.87 | 620.48 | 538.92 | 620.52 | 561.08 | 689.98 | Upgrade
|
| Selling, General & Admin | 335.04 | 332.38 | 297.92 | 397.63 | 407.59 | 401.45 | Upgrade
|
| Other Operating Expenses | -31.37 | -23.31 | -28.27 | -25.58 | -10.83 | -15.05 | Upgrade
|
| Operating Expenses | 303.67 | 309.07 | 269.65 | 372.06 | 396.76 | 386.41 | Upgrade
|
| Operating Income | 367.2 | 311.4 | 269.27 | 248.47 | 164.33 | 303.57 | Upgrade
|
| Interest Expense | -51.79 | -78.71 | -61.41 | -25.69 | -30.14 | -55.36 | Upgrade
|
| Interest & Investment Income | 18.93 | 27.68 | 17.88 | 3.02 | 2.09 | 5.73 | Upgrade
|
| Earnings From Equity Investments | -0.04 | 0.17 | -1.63 | -3.77 | -5.53 | 0.63 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.58 | -0.1 | 0.36 | 0.05 | -1.58 | 0.25 | Upgrade
|
| EBT Excluding Unusual Items | 334.89 | 260.44 | 224.47 | 222.08 | 129.17 | 254.82 | Upgrade
|
| Merger & Restructuring Charges | - | - | - | - | - | -0.4 | Upgrade
|
| Gain (Loss) on Sale of Investments | -0.75 | 1.62 | - | 3.3 | 7.46 | - | Upgrade
|
| Gain (Loss) on Sale of Assets | -2.53 | -0.05 | -3.42 | 0.25 | 1.07 | -0.36 | Upgrade
|
| Asset Writedown | -20.51 | -7.43 | - | 5.55 | 0.49 | 1.2 | Upgrade
|
| Other Unusual Items | - | - | 29.3 | 0.25 | 82.39 | 8.22 | Upgrade
|
| Pretax Income | 311.1 | 254.58 | 250.35 | 231.43 | 220.57 | 263.49 | Upgrade
|
| Income Tax Expense | 57.92 | 44.41 | 42.98 | 43.73 | 34.26 | 46.03 | Upgrade
|
| Earnings From Continuing Operations | 253.18 | 210.17 | 207.37 | 187.71 | 186.31 | 217.46 | Upgrade
|
| Earnings From Discontinued Operations | - | 80.61 | 75.84 | - | 0 | 1.65 | Upgrade
|
| Net Income to Company | 253.18 | 290.78 | 283.21 | 187.71 | 186.31 | 219.11 | Upgrade
|
| Minority Interest in Earnings | 0.04 | -23.81 | -32.17 | -10.04 | -12.6 | -3.48 | Upgrade
|
| Net Income | 253.22 | 266.97 | 251.04 | 177.67 | 173.71 | 215.63 | Upgrade
|
| Net Income to Common | 253.22 | 266.97 | 251.04 | 177.67 | 173.71 | 215.63 | Upgrade
|
| Net Income Growth | -5.83% | 6.34% | 41.30% | 2.28% | -19.44% | -13.94% | Upgrade
|
| Shares Outstanding (Basic) | 1,957 | 1,920 | 1,911 | 1,916 | 1,916 | 1,983 | Upgrade
|
| Shares Outstanding (Diluted) | 1,957 | 1,920 | 1,912 | 1,916 | 1,916 | 1,983 | Upgrade
|
| Shares Change (YoY) | 2.53% | 0.44% | -0.21% | -0.03% | -3.37% | 2.71% | Upgrade
|
| EPS (Basic) | 0.13 | 0.14 | 0.13 | 0.09 | 0.09 | 0.11 | Upgrade
|
| EPS (Diluted) | 0.13 | 0.14 | 0.13 | 0.09 | 0.09 | 0.11 | Upgrade
|
| EPS Growth | -8.18% | 5.86% | 41.57% | 2.30% | -16.63% | -16.21% | Upgrade
|
| Free Cash Flow | 355.88 | 354.85 | 567.09 | 343.08 | 345.9 | 276.96 | Upgrade
|
| Free Cash Flow Per Share | 0.18 | 0.18 | 0.30 | 0.18 | 0.18 | 0.14 | Upgrade
|
| Dividend Per Share | 0.065 | 0.055 | 0.052 | 0.039 | 0.023 | 0.045 | Upgrade
|
| Dividend Growth | 33.20% | 6.18% | 33.51% | 68.70% | -48.89% | 0% | Upgrade
|
| Gross Margin | 42.92% | 42.27% | 42.51% | 38.89% | 38.80% | 43.91% | Upgrade
|
| Operating Margin | 23.50% | 21.22% | 21.24% | 15.57% | 11.36% | 19.32% | Upgrade
|
| Profit Margin | 16.20% | 18.19% | 19.80% | 11.14% | 12.01% | 13.72% | Upgrade
|
| Free Cash Flow Margin | 22.77% | 24.18% | 44.74% | 21.50% | 23.92% | 17.62% | Upgrade
|
| EBITDA | 470.84 | 415.94 | 380.38 | 391.76 | 299.89 | 415.61 | Upgrade
|
| EBITDA Margin | 30.13% | 28.34% | 30.01% | 24.55% | 20.74% | 26.45% | Upgrade
|
| D&A For EBITDA | 103.64 | 104.53 | 111.12 | 143.29 | 135.57 | 112.04 | Upgrade
|
| EBIT | 367.2 | 311.4 | 269.27 | 248.47 | 164.33 | 303.57 | Upgrade
|
| EBIT Margin | 23.50% | 21.22% | 21.24% | 15.57% | 11.36% | 19.32% | Upgrade
|
| Effective Tax Rate | 18.62% | 17.45% | 17.17% | 18.89% | 15.53% | 17.47% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.